We are live on
!
Find out more
RSC
Red Spruce Capital Portfolio holdings
AUM
$287M
1-Year Est. Return
38.81%
This Fund
S&P 500
This Quarter
Est. Return
+8.12%
1 Year Est. Return
+38.81%
3 Year Est. Return
+93.31%
5 Year Est. Return
+110.88%
10 Year Est. Return
–
AUM
$186M
AUM Growth
+$14.8M
(+8.7%)
Cap. Flow
+$3.63M
Cap. Flow
% of AUM
1.95%
Top 10 Holdings %
Top 10 Hldgs %
34.48%
Holding
94
New
5
Increased
38
Reduced
27
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.49M |
| 2 |
PayPal
PYPL
|
+$1.23M |
| 3 |
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
|
+$1.11M |
| 4 |
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
|
+$625K |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$518K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.58M |
| 2 |
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
|
+$802K |
| 3 |
Broadcom
AVGO
|
+$592K |
| 4 |
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
|
+$541K |
| 5 |
Edwards Lifesciences
EW
|
+$523K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.06% |
| 2 | Healthcare | 14.61% |
| 3 | Industrials | 10.2% |
| 4 | Communication Services | 9.06% |
| 5 | Financials | 7.44% |
Similar funds
AWM
GCM
EA
MAG
IRAG
WMR
PAM
VU
Red Spruce Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Red Spruce Capital held 94 positions worth $186M, up 8.7% from $171M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Red Spruce Capital's Q2 2023 filing shows 5 new, 38 increased, 27 reduced and 3 closed positions. Its largest new stake was Invesco BulletShares 2029 Corporate Bond ETF: 26,616 shares worth $478K. The largest sale was Merck, an estimated $1.58M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.
- Red Spruce Capital's largest Q2 2023 buy was Invesco BulletShares 2029 Corporate Bond ETF: 26,616 shares worth $478K.
- Red Spruce Capital added most to AbbVie in Q2 2023, an estimated $1.49M increase.
- Red Spruce Capital's biggest Q2 2023 reduction was Merck, cutting an estimated $1.58M.
- Red Spruce Capital fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q2 2023, selling an estimated $541K.
- Red Spruce Capital's ten largest holdings make up 34% of its $186M portfolio in Q2 2023.
- Red Spruce Capital opened 5 new positions and closed 3 in Q2 2023.
- Red Spruce Capital's portfolio value rose 8.7% quarter-over-quarter to $186M.
Based on Red Spruce Capital's 13F filing for Q2 2023, filed 5 Jul 2023.